Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

06/02/2025 4 min
Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

Listen "Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment"

Episode Synopsis

In this week's podcast, Neurology Today's editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.  

More episodes of the podcast Neurology Today in 5